Effect of Flavonoids on Human Health: Old Subjects but New Challenges

Recent Patents on Biotechnology

Volumn 1, Issue 2, 2007, Pages 139-150

  Lee, Eung Ryoung ^a   Kang, Geun Ho ^a   Cho, Ssang Goo ^a  

^a Konkuk University   (South Korea)

Author keywords

anti cancer; anti diabetic; anti oxidant; anti viral; cardiovascular disease; flavonoids; Polyphenol

Indexed keywords

DISEASES; OXIDANTS; PATENTS AND INVENTIONS;

ANTI-CANCER; ANTI-OXIDANTS; ANTI-VIRAL; ANTIDIABETIC; CARDIOVASCULAR DISEASE; FLAVONOID; HEALTH EFFECTS; HUMAN HEALTH; PLANT PIGMENTS; POLYPHENOLS;

FLAVONOIDS;

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; ENZYME INHIBITOR; FLAVONOID; HORMONE; IMMUNOLOGIC FACTOR; PIGMENT;

BEVERAGE; CHEMISTRY; DIET; FRUIT; HUMAN; PATENT; REVIEW; VEGETABLE;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ANTIVIRAL AGENTS; BEVERAGES; DIET; ENZYME INHIBITORS; FLAVONOIDS; FRUIT; HORMONES; HUMANS; IMMUNOLOGIC FACTORS; PATENTS AS TOPIC; PIGMENTS, BIOLOGICAL; VEGETABLES;

EID: 58849095528     PISSN: 18722083     EISSN: 22124012     Source Type: Journal    
DOI: 10.2174/187220807780809445     Document Type: Article

References (98)

1. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81: 317-325.
2. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002; 96: 67-202.
3. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673-751.
4. de Vries JH, Janssen PL, Hollman PC, van Staveren WA, Katan MB. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett 1997; 19: 141-144.
5. Pan Y, Zhao L, Liang J, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006; 20: 1886-1888.
6. Gu Y, Zhu CF, Iwamoto H, Chen JS. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol. 2005; 11: 6512-6517.
7. Lansky, E. P.: US20020012710A1 (2002).
8. Artik N, Cemeroglu B, Burakami H, Mori T. Determination of phenolic compounds in pomegranate juice by HPLC. Fruit Process 1998; 8: 492-499.
9. Ben Nasr C, Ayed N, and Metche M. Quantitative determination of the polyphenolic content of pomegranate peel. Z Lebensm Unters Forsch 1996; 203: 374-378.
10. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 1999; 66: 11-17.
11. Moneam NM, el Sharaky AS, Badreldin MM. Oestrogen content of pomegranate seeds. J Chromatogr. 1988; 438: 438-442.
12. Abd El Wahab SM, El Fiki SF, Mostafa, SF, Hassan AEB. Characterization of certain steroid hormones in Punica granatum L. seeds. Bulletin of the Faculty of Pharmacy of Cairo University 1998; 36: 11-158.
13. Aylward, J. H.: US20020076457A1 (2002).
14. Jiang, B.H., Fang, J.: US20060189680A1 (2006).
15. Liu, Y.: US20040072790A1 (2004).
16. Young, C., Xing, N.: US20030054053A1 (2003).
17. Winsor, R.: US20060159543A1 (2006).
18. Leahy, M. M., Starr, M., Kurowska, E., Guthrie, N.: US20020054924A1 (2002).
19. Nair, M. G., Bourquin, L. D., Seeram, N. P., Kang, S.Y.: US20010016573A1 (2001).
20. Zhao C, Giusti MM, Malik M, Moyer MP, Magnuson BA. J Agric. Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic. Food Chem 2004; 52: 6122-6128.
21. Nair, M. G.., Zhang, Y., Vareed, S. K.: US20040132672A1 (2004).
22. Gray, J. I., Booren, A. M., Nair, M. G.., Strasburg, G. M., Wang, H., Gomaa, E. A., Chang, Y. C.: US5985636 (1999).
23. Nair, M. G., Wang, H., Strasburg, G. M., Booren, A. M., Gray, J. I.: US20016194469A1 (2001).
24. Magnuson, B. A., Giusti, M. M., Malik, M., Zhao, C.: US20050013880A1 (2005).
25. Lee, H.Y.: US20060128792A1 (2006).
26. Pandol, S. J., Gukovskaya, A., Yazbeck, M., Eibl, G., Boros, L G.: 20040259816A1 (2004).
27. Ratain, M. J., Innocenti, F., Iyer, L.: US20020016293A1 (2002).
28. Kattige, S. L., Naik, R. G., Lakdawalla, A. D., Dohadwalla, A. N., Rupp, R. H., De Souza, N.J.: US4900727 (1990).
29. Kim KS, Sack JS, Tokarski JS, et al. Thio-and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. J Med Chem 2000; 43: 4126-4134.
30. Mansuri, M. M., Murthi, K. K., Pal, K.: US5733920 (1998).
31. Dent, P., Grant, S., Krystal, G., Yu, C.: US20050176725A1 (2005).
32. Vesely J, Havlicek L, Strnad M, et al. Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 1994; 224: 771-786.
33. Abraham RT, Acquarone M, Andersen A, et al. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol Cell 1995; 83: 105-120.
34. Kramer, J. B., Showalter, H. D. H.: US20020061865A1 (2002).
35. Tucker, J., McCaffrey, D., Wong, N. C.W.: US20050080021A1 (2005).
36. Ross R. Mechanisms of Disease: Atherosclerosis-An Inflammatory Disease. N Engl J Med 1999; 340: 115-126.
37. Sabbadini, R. A.: US20030096022A1 (2003).
38. Mruk, J. S.: US20010041687A1 (2001).
39. Guthrie, N., Kurowska, E. M., Manthey, J. A.: US20040214882A1 (2004).
40. Green, N., McArdle, R. N., McGill, C., Mellican, R., Parshall, K.: US20040022877A1 (2004).
41. Widlansky ME, Duffy SJ, Hamburg NM, et al. Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Radic Biol Med 2005; 38: 499-506.
42. Grabiel, R. D., Strickland, C. A.: US20040131749A1 (2004).
43. Romanczyk, L. J. JR., Schmitz, H. H.: US20050267052A1 (2005).
44. Jalili, T.: US20040258674A1 (2004).
45. Guthrie, N.: US20050227930A1 (2005).
46. Tucker, J., McCaffrey, D., Wong, N. C.W.: US20050080024A1 (2005).
47. Soto, P., Claudia, A.: US20060041009A1 (2006).
48. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006; 79: 1578-1584.
49. Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Hardman JG et al., eds. Goodman&Gilman's The pharmacological basis of therapeutics. 9th ed. 1996: 1507-1511.
50. Ziegler, R.: US20050181076A1 (2005).
51. Nakajima M, Cooney MJ, Tu AH, et al. Invest Ophthalmol Vis Sci 2001; 42: 2110-2114.
52. Landers, Robert A.: US20050137147A1 (2005).
53. Soares Da Silva, P.: US20040242503A1 (2004).
54. Zhao, Y., Yang, M., Li, Y., Luan, X., Luo, Z.: US20040132671A1 (2004).
55. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-766.
56. Thorsett ED, Latimer LH. Therapeutic approaches to Alzheimer's disease. Curr Opin Chem Biol 2000; 4: 377-382.
57. Klein WL, Krafft GA, Finch CE. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 2001; 24: 219-224.
58. Lin, Y. M., Zembower, D. E., Flavin, M. T., Schure, R., Zhao, G. X.: US20020068757A1 (2002).
59. Buchholz, H., Wagner, A., Kraus, C., Meduski, J. D.: US20020151599A1 (2002).
60. Berg, K. F.: US20040053858A1 (2004).
61. Berg, K. F.: US20060148726A1 (2006).
62. Mann, D. M., Drohan, W. N., MacPhee, M. J., Burgess, W.: US20030059338A1 (2003).
63. Hughes DA. Effects of carotenoids on human immune function. Proc Nutr Soc 1999; 58: 713-718.
64. Hellstrand, J. U. K., Hermodsson, S. H.: US20020119119A1 (2002).
65. Phinney, S. D., Dreon, D. M.: US20050137253A1 (2005).
66. Theoharides, T. C.: US20030229030A1 (2003).
67. Phinney, S. D., Dreon, D. M.: US20030144219A1 (2003).
68. Tehoharides, T. C.: US20060013905A1 (2006).
69. Kuhrts, E. H.: US20070003646A1 (2007).
70. Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6',7'-Dihydroxy-bergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999; 65: 237-244.
71. Latchman DS. Heat shock proteins: Protective effect and potential therapeutic use. Int J Mol Med 1998; 2: 375-381.
72. Santoro A, Scopa A, Bufo SA, Mansour M, Mountacer H. Photodegradation of the triazole fungicide hexaconazole. Bull Environ Contam Toxicol 2000; 64: 475-480.
73. Porta, A.: US20040266699A1 (2004).
74. Caldwell, S. T., Bennett, C. J., Hartley, R.C., McPhail, D. B., Duthie, G.. G.: US20060137207A1 (2006).
75. Lee ER, Kang YJ, Kim JH, Lee HT, Cho SG. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem 2005; 280: 31498-31507.
76. Lee ER, Kim JH, Kang YJ, Cho SG.. The anti-apoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes. Biol Pharm Bull 2007; 30: 32-37.
77. Leko, V.: US20077172774 (2007).
78. Fremont L, Belguendouz L, Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci 1999; 64: 2511-2521.
79. Yokomizo A, Moriwaki M. Effects of uptake of flavonoids on oxidative stress induced by hydrogen peroxide in human intestinal Caco-2 cells. Biosci Biotechnol Biochem 2006; 70: 1317-1324.
80. Van Norren, K., Van Hoorn, E. C., Leuvenink, H. G. D., Hofman, Z.: US20040076692A1 (2004).
81. Pandol, S. J., Gukovskaya, A.: US20040063648A1 (2004).
82. Obukowicz, M. G., Hummert, S. L.: US20020136784A1 (2002).
83. Kuhrts, E. H.: US20030091656A1 (2003).
84. Jia, Q., Nichols, T. C., Rhoden, E. E., Waite, S.: US20060269627A1 (2006).
85. Denny, W. A., Rewcastle, G.W., Dobrusin, E., Kramer, J. B., McNamara, D. J., Showalter, H. D. H., Toogood, P. L.: US20030130286A1 (2003).
86. Tomohisa N, Hirofumi Y, General syntheses of 1-alkyltoxoflavin and 8-alkylfervenulin derivatives of biological significance by the regioselective alkylation of reumycin derivatives and the rates of transalkylation from 1-alkyltoxoflavins into nucleophiles. J Chem Soc Perkin Trans 2001; 2: 130-137.
87. LaCrampe, J. F. A., Connors, R. W., Ho, C. Y., Richardson A., Freyne, E. J. E., Buijnsters, P. J. J., Bakker, A. C.: US20060040943A1 (2006).
88. LaCrampe, J. F. A., Connors, R. W., Ho, C. Y., Richardson A., Freyne, E. J. E., Buijnsters, P. J. J., Bakker, A. C.: US20050239784A1 (2005).
89. Hsu, L. W., Chang, S.C., Shen, C. H., Liao, Y.-X. Chuang, K.-S.: US20060105967A1 (2006).
90. Sonnenbichler J, Pohl A. Mechanism of silybin action, IV. Structure-action relationship (author's transl) Hoppe Seylers Z Physiol Chem 1980; 361: 1757-1761.
91. Cleveland, T. E., Boue, S. M., Burow; M. E., McLachlan, J. A.: US20060246162A1 (2006).
92. Negrao MR, Keating E, Faria A, Azevedo I, Martins MJ. Acute effect of tea, wine, beer, and polyphenols on ecto-alkaline phosphatase activity in human vascular smooth muscle cells. J Agric Food Chem 2006; 54: 4982-4988.
93. Zielinska-Przyjemska M, Dobrowolska-Zachwieja A. Pol Merkur Lekarski. Effect of tea polyphenols on oxidative metabolism of polymorphonuclear neutrophils in healthy and obese people. Pol Merkur Lekarski 2005; 19: 41-47.
94. Calias P, Galanopoulos T, Maxwell M, Khayat A, Graves D, Antoniades HN, d'Alarcao M. Synthesis of inositol 2-phosphate-quercetin conjugates. Carbohydr Res 1996; 292: 83-90.
95. Kusuda M, Hatano T, Yoshida T. Water-soluble complexes formed by natural polyphenols and bovine serum albumin: evidence from gel electrophoresis. Biosci Biotechnol Biochem 2006; 70: 152-160.
96. Orsolic N, Basic I. Water-soluble derivative of propolis and its polyphenolic compounds enhance tumoricidal activity of macrophages. J Ethnopharmacol 2005; 102: 37-45.
97. Chomczynski, P.: US20060121133A1 (2006).
98. Deby, C., Dupont, G., Serteyn, D.: US20060252707A1 (2006).